Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). (Q40159917)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 October 2007
edit
Language Label Description Also known as
English
Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
scientific article published on 26 October 2007

    Statements

    Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study) (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit